Δ5-Cholenoyl-amino acids as selective and orally available antagonists of the Eph–ephrin system

This publication has 50 references indexed in Scilit:

• Structure–Activity Relationships and Mechanism of Action of Eph–ephrin Antagonists: Interaction of Cholanic Acid with the EphA2 Receptor
  ChemMedChem, 2012
• Novel Targeted System To Deliver Chemotherapeutic Drugs to EphA2-Expressing Cancer Cells
  Journal of Medicinal Chemistry, 2012
• A Disalicylic Acid‐Furanyl Derivative Inhibits Ephrin Binding to a Subset of Eph Receptors
  Chemical Biology & Drug Design, 2011
• Eph receptors and ephrins in cancer: bidirectional signalling and beyond
  Nature Reviews Cancer, 2010
• TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis
  Cell Metabolism, 2009
• Ligand recognition by A‐class Eph receptors: crystal structures of the EphA2 ligand‐binding domain and the EphA2/ephrin‐A1 complex
  EMBO Reports, 2009
• The EphA2 Receptor and EphrinA1 Ligand in Solid Tumors: Function and Therapeutic Targeting
  Molecular Cancer Research, 2008
• Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer
  British Journal of Cancer, 2008
• Eph-Ephrin Bidirectional Signaling in Physiology and Disease
  Cell, 2008
• Cell–cell signaling via Eph receptors and ephrins
  Current Opinion in Cell Biology, 2007